Quest PharmaTech Inc.
QPT.V
TSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 41.60K | 67.40K | 42.80K | 141.70K | 133.70K |
| Total Receivables | -- | -- | -- | -- | 89.70K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 18.20K | 3.70K | 14.60K | 14.00K | 19.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 59.70K | 71.00K | 57.40K | 155.70K | 243.40K |
|
|
|||||
| Total Current Assets | 59.70K | 71.00K | 57.40K | 155.70K | 243.40K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.20K | 4.20K | 4.20K | 4.00K | 4.20K |
| Total Assets | 17.36M | 16.69M | 16.76M | 15.59M | 17.37M |
|
|
|||||
| Total Accounts Payable | 124.50K | 74.80K | 300.00 | 72.10K | 42.40K |
| Total Accrued Expenses | 56.60K | 53.60K | 50.00K | 44.30K | 16.20K |
| Short-term Debt | 713.60K | 722.60K | 723.70K | 690.90K | 717.60K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 894.70K | 851.00K | 774.00K | 807.30K | 776.20K |
|
|
|||||
| Total Current Liabilities | 894.70K | 851.00K | 774.00K | 807.30K | 776.20K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 713.60K | 722.60K | 723.70K | 690.90K | 717.60K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 894.70K | 851.00K | 774.00K | 807.30K | 776.20K |
|
|
|||||
| Common Stock & APIC | 30.33M | 30.66M | 30.71M | 29.32M | 30.45M |
| Retained Earnings | -13.76M | -14.71M | -14.61M | -14.43M | -13.77M |
| Treasury Stock & Other | -103.20K | -109.20K | -110.80K | -104.70K | -84.90K |
| Total Common Equity | 16.47M | 15.83M | 15.99M | 14.78M | 16.59M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 16.47M | 15.83M | 15.99M | 14.78M | 16.59M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 16.47M | 15.83M | 15.99M | 14.78M | 16.59M |
|
|
|||||